PT  - JOURNAL ARTICLE
AU  - Lakhdari, Nordine
AU  - Tabet, Boualem
AU  - Boudraham, Lila
AU  - Laoussati, Malha
AU  - Aissanou, Sofiane
AU  - Beddou, Lamia
AU  - Bensalem, Sihem
AU  - Bellik, Yuva
AU  - Bournine, Lamine
AU  - Fatmi, Sofiane
AU  - Iguer-Ouada, Mokrane
TI  - Red blood cells injuries and hypersegmented neutrophils in COVID-19 peripheral blood film
AID  - 10.1101/2020.07.24.20160101
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.07.24.20160101
4099  - http://medrxiv.org/content/early/2020/07/30/2020.07.24.20160101.short
4100  - http://medrxiv.org/content/early/2020/07/30/2020.07.24.20160101.full
AB  - In the current investigation, peripheral blood films of 15 COVID-19 patients (44.78±16.55 years), proven by computed tomographic imaging and RT-PCR for coronavirus SARS-CoV-2, were analyzed at the moment of hospital admission. Blood tests showed raised inflammatory markers (C-reactive protein 58.2±61.2 mg/L) with normal values for hemoglobin (126.2±2.6 g/L), WBC (6.8±18.74 109/L) RBC (4.55±0.99 1012/L) platelets (262.4±141.8, 109/L) MCV (79.84±8.2 fL) MCH (28±3.31 pg) and MCHC (350.3±1.15 g/L). The results revealed the presence of hypersegmented neutrophils in 66.66%% of the patients. The percentages of neutrophils with 4 and 5 lobes were 46.25 ± 4.83% and 31.5 ± 14.84%, respectively. Three major red blood cells morphological alteration were observed: (1) erythrocytes in “rouleaux” formation represented by linear erythrocytes aggregation, (2) spherocytes with the disappearance of the usual biconcave disk, and (3) echinocytes showing spiky projections. Apparent reorganization of hemoglobin is found in the majority of the analyzed erythrocytes. Rouleaux formation is observed in 33.33% of patients and spherocytes and echinocytes are present at variable levels in the all analyzed patients. The current results revealed erythrocytes injuries in COVID-19 peripheral blood, in association with hypersegmented neutrophils, alterations that could be involved in the respiratory syndrome.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThere is no funding in the current researchAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Medicine Scientific committeeAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data present in the current study are available at the University of Bejaia